Followers | 176 |
Posts | 16221 |
Boards Moderated | 0 |
Alias Born | 11/10/2008 |
Tuesday, February 14, 2023 10:03:31 AM
Actually, I am at a loss to see GTCH trade action like this. Normally, prior to 2020, the PR would have jacked up the volume and create a much higher pps spike. Times have changed. MMs have gained much more control over their manipulation. I have yet to devise any 'technique' that benefits MMs purpose.
No spike, no shorting? No spike, dilution with input of new shares? Retail traders unloading 'old' shares that are profitable selling at 4? Or ALL factors' shoot out? Up to my imagination as to how many scenarios I want to invent. What the hell is keeping such a run on 4s, both from the buy and sell sides. Over a hundred million volume and still, the floor is 4s!!!
I simply do not understand why????
Recent GTCH News
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:32:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:16:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:07:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2023 09:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 09:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 08:06:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 10:04:19 AM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 08/23/2023 10:01:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2023 12:00:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/17/2023 10:15:52 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 11:19:14 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:05:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:05:52 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 07/28/2023 08:05:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 08:05:43 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM